Posted by jealibeanz on March 10, 2007, at 18:24:49
In reply to Re: GSK and Fabre-Kramer make agreement on Gepiron » Cecilia, posted by River1924 on March 10, 2007, at 18:01:37
> It was refused once. Besides newer clinical trials (I believe it was being tested as a treatment for atypical depression at one point), it will have a much better chance of passing the fda because a huge pharmaceutical is involved. For better or worse, they have more contacts.
>
> Also, I doubt if GSK would have bothered paying for a med if they weren't pretty sure it would get a pass from the fda eventually.True. Very true. Company name/establishment will make a big difference with the up and coming drugs for sure.
poster:jealibeanz
thread:731652
URL: http://www.dr-bob.org/babble/20070308/msgs/739973.html